Daniel Kwon
About Daniel Kwon
Daniel Kwon is a Senior Analyst in Investments at Roivant Sciences, where he has worked since 2020. He has a background in clinical operations and research, having previously held positions at Aruvant, NYU Langone Health, and Duke University.
Work at Roivant Sciences
Daniel Kwon has been employed at Roivant Sciences as a Senior Analyst in Investments since 2020. In this role, he is based in New York, New York, where he focuses on investment strategies and analysis within the biopharmaceutical sector. His responsibilities include assessing potential investment opportunities and supporting the company's overall investment strategy.
Previous Experience in Clinical Operations
Prior to his current role, Daniel Kwon worked at Aruvant as an Analyst in Clinical Operations from 2019 to 2020. His tenure lasted for seven months, during which he contributed to the management and analysis of clinical operations, enhancing the efficiency of clinical trials and operations within the organization.
Internship at NYU Langone Health
In 2017, Daniel Kwon served as a Clinical Intern at NYU Langone Health, specifically at Bellevue Hospital. This internship lasted for three months and provided him with hands-on experience in a clinical setting, where he gained insights into healthcare operations and patient care.
Research Experience at Duke University
Daniel Kwon has extensive research experience from his time at Duke University. He worked as a Research Assistant at the Bryan Alzheimer's Disease Research Center from 2016 to 2019 for three years, where he contributed to research initiatives focused on Alzheimer's disease. Additionally, he was a Research Assistant at the Duke Global Health Institute from 2017 to 2019 for two years, where he engaged in projects related to global health issues.
Education in Neuroscience and Global Health
Daniel Kwon earned a Bachelor's Degree in Neuroscience and Global Health from Duke University, completing his studies from 2015 to 2019. His educational background provided him with a strong foundation in both neuroscience and global health, equipping him with the knowledge necessary for his subsequent roles in clinical operations and investments.